Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study

In the UK, 10% of patients diagnosed with rectal cancer have inoperable disease at presentation. This study ascertained whether the resectability rate of inoperable locally advanced rectal cancer was improved by administration of intravenous irinotecan, 5-fluorouracil (5-FU) and pelvic radiotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Iles, S M, Gollins, S W, Susnerwala, S, Haylock, B, Myint, S, Biswas, A, Swindell, R, Levine, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359647/
https://www.ncbi.nlm.nih.gov/pubmed/18349840
http://dx.doi.org/10.1038/sj.bjc.6604292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359647/
https://www.ncbi.nlm.nih.gov/pubmed/18349840
http://dx.doi.org/10.1038/sj.bjc.6604292

Ejemplares similares